Progressive atrophy of cerebellum and brainstem as a function of age and the size of the expanded CAG repeats in the MJD1 gene in Machado-Joseph disease

Annals of Neurology

Volumn 43, Issue 3, 1998, Pages 288-296

  Onodera, Osamu ^a   Idezuka, Jiro ^a   Igarashi, Shuichi ^a   Takiyama, Yoshihisa ^b   Endo, Kotaro ^a   Takano, Hiroki ^a   Oyake, Mutsuo ^a   Tanaka, Hajime ^a   Inuzuka, Takashi ^a   Hayashi, Tsunemi ^c   Yuasa, Tatsuhiko ^d   Ito, Jusuke ^a   Miyatake, Tadashi ^e   Tsuji, Shoji ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c Nishi Ojiya National Hospital   (Japan)

^d 1 7 1 Kohnodai   (Japan)

^e SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BRAIN ATROPHY; CEREBELLAR ATAXIA; CHROMOSOME 14Q; CLINICAL ARTICLE; CLINICAL FEATURE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GENE LOCATION; HUMAN; MACHADO JOSEPH DISEASE; MALE; MUSCLE ATROPHY; NERVE DEGENERATION; PATHOGENESIS; PRIORITY JOURNAL; TRINUCLEOTIDE REPEAT;

ADULT; AGED; AGING; ATROPHY; BRAIN STEM; CEREBELLUM; FEMALE; HUMANS; MACHADO-JOSEPH DISEASE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPETITIVE SEQUENCES, NUCLEIC ACID;

EID: 0031914409     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410430305     Document Type: Article

References (38)

1. Sequeiros J, Coutinho P. Epidemiology and clinical aspects of Machado-Joseph disease. Adv Neurol 1993;61:139-153
2. Rosenberg RN, Nyhan WL, Bay C, Shore P. Autosomal dominant striatonigral degeneration: a clinical, pathologic, and biochemical study of a new genetic disorder. Neurology 1976;26: 703-714.
3. Kawaguchi Y, Okamoto T, Taniwaki M, et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet 1994;8:221-228
4. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72:971-983
5. Banfi S, Servadio A, Chung MY, et al. Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nat Genet 1994;7:513-520
6. Nagafuchi S, Yanagisawa H, Sato K, et al. Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nat Genet 1994;6:14-18
7. Koide R, Ikeuchi T, Onodera O, et al. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet 1994;6:9-13
8. La Spada AR, Wilson EM, Lubahn DB, et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991;352:77-79
9. Imbert G, Saudou F, Yvert G, et al. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat Genet 1996;14:285-291
10. Pulst SM, Nechiporuk A, Nechiporuk T, et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet 1996;14:269-276
11. Sanpei K, Takano H, Igarashi S, et al. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT Nat Genet 1996;14:277-284
12. Nagafuchi S, Yanagisawa H, Ohsaki E, et al. Structure and expression of the gene responsible for the triplet repeat disorder, dentatorubral and pallidoluysian atrophy (DRPLA). Nat Genet 1994;8:177-182
13. Onodera O, Oyake M, Takano H, et al. Molecular cloning of a full-length cDNA for dentatorubral-pallidoluysian atrophy and regional expressions of the expanded alleles in the CNS. Am J Hum Genet 1995;57:1050-1060
14. Chang C, Kokontis J, Liao S. Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 1988;240:324-326
15. Igarashi S, Tanno Y, Onodera O, et al. Strong correlation between the number of CAG repeats in androgen receptor genes and the clinical onset of features of spinal and bulbar muscular atrophy. Neurology 1992;42:2300-2302
16. La Spada AR, Roling DB, Harding AE, et al. Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nat Genet 1992;2:301-304
17. Duyao M, Ambrose C, Myers R, et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Genet 1993;4:387-392
18. Andrew SE, Goldberg YP, Kremer B, et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet 1993;4:398-403
19. Orr HT, Chung MY, Banfi S, et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet 1993;4:221-226
20. Ikeuchi T, Koide R, Tanaka H, et al. Dentatorubral-pallidoluysian atrophy: clinical features are closely related to unv stable expansions of trinucleotide (CAG) repeat. Ann Neurol 1995;37:769-775
21. Takiyama Y, Igarashi S, Rogaeva EA, et al. Evidence for intergenerational instability in the CAG repeat in the MJD1 gene and for conserved haplotypes at flanking markers amongst Japanese and Caucasian subjects with Machado-Joseph disease. Hum Mol Genet 1995;4:1137-1146
22. Maruyama H, Nakamura S, Matsuyama Z, et al. Molecular features of the CAG repeats and clinical manifestation of Machado-Joseph disease. Hum Mol Genet 1995;4:807-812
23. Hirayama K, Takayanagi T, Nakamura R, et al. Spinocerebellar degenerations in Japan: a nationwide epidemiological and clinical study. Acta Neurol Scand Suppl 1994;153:1-22
24. Hirayama K, Takayanagi T, Yanagisawa N. Ataxic diseases (spinocerebellar degenerations and Shy-Drager syndrome): epidemiologic study. Annual Report of Research Committee for Ataxic Diseases 1990
25. Reiss AL, Aylward E, Freund LS, et al. Neuroanatomy of fragile X syndrome: the posterior fossa. Ann Neurol 1991;29:26-32
26. Idezuka J, Onodera O, Yuasa T, et al. MRI findings of olivopontocerebellar atrophy and Machado-Joseph disease -diagnostic value of transverse pontine fibers. Rinsho Shinkeigaku 1993;33:289-293
27. Savoiardo M, Strada L, Girotti F, et al. Olivopontocerebellar atrophy: MR diagnosis and relationship to multisystem atrophy. Radiology 1990;174:693-696
28. Hayakawa K, Konishi Y, Matsuda T, et al. Development and aging of brain midline structures: assessment with MR imaging. Radiology 1989;172:171-177
29. Myers RH, Vonsattel JP, Stevens TJ, et al. Clinical and neuropathologic assessment of severity in Huntington's disease. Neurology 1988;38:341-347
30. Illarioshkin SN, Igarashi S, Onodera O, et al. Trinucleotide repeat length and rate of progression of Huntington's disease. Ann Neurol 1994;36:630-635
31. Furtado S, Suchowersky O, Rewcastle B, et al. Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease. Ann Neurol 1996;39:132-136
32. Kogure T, Oda T, Katoh Y. Autopsy cases of hereditary ataxia pathologically diagnosed as the Japanese type of Joseph disease: cliniconeuropathological findings. Seishin Shinkeigaku Zasshi 1990;92:161-183
33. Iwabuchi K, Kogure T, Oda T, et al. Some problems on the clinical phenotype of Machado-Joseph disease in relation between their ages at onset. No To Shinkei 1993;45:246-254
34. Iwabuchi K, Nagatomo H, Hanihara T, et al. Clinicopathological study on autosomal dominant hereditary spastic ataxia (Greenfield): its relationship to ataxo-choreoathetosis form of DRPLA, spinopontine degeneration, Machado-Joseph disease, and SCA3. Adv Neurol Sci 1995;39:164-187
35. Iwabuchi K, Yagishita S, Amano N, et al. A clinicopathological study on autosomal dominant hereditary dentatorubropallidoluysian atrophy (Naitoh-Oyanagi's disease). Adv Neurol Sci 1993;37:678-692
36. Takahashi H, Ohama E, Naito H, et al. Hereditary dentatorubral-pallidoluysian atrophy: clinical and pathologic variants in a family. Neurology 1988;38:1065-1070
37. Takeda S, Takahashi H, Ikuta F. Dentatorubropallidoluysian atrophy (DRPLA): comparative pathological study on clinical groups classified into juvenile, early adult and late adult types. No To Shinkei 1992;44:111-116
38. Aylward EH, Brandt J, Codori AM, et al. Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons. Neurology 1994;44:823-828